First description of DHA-1 ampC β-lactamase in Proteus mirabilis
- 1 July 2005
- journal article
- Published by Elsevier in Clinical Microbiology & Infection
- Vol. 11 (7) , 591-592
- https://doi.org/10.1111/j.1469-0691.2005.01178.x
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- First Report of Salmonella Isolates with the DHA-1 AmpC β-Lactamase in the United KingdomAntimicrobial Agents and Chemotherapy, 2004
- Epidemiology of Conjugative Plasmid-Mediated AmpC β-Lactamases in the United StatesAntimicrobial Agents and Chemotherapy, 2004
- Characterization of CMY-type beta-lactamases in clinical strains of Proteus mirabilis and Klebsiella pneumoniae isolated in four hospitals in the Paris areaJournal of Antimicrobial Chemotherapy, 2002
- Emergence of Klebsiella pneumoniae Isolates Producing Inducible DHA-1 β-Lactamase in a University Hospital in TaiwanJournal of Clinical Microbiology, 2002
- Plasmid-Mediated Cephalosporinase ACC-1 in Clinical Isolates of Proteus mirabilis and Escherichia coliEuropean Journal of Clinical Microbiology & Infectious Diseases, 2000
- Salmonella enteritidis : AmpC Plasmid-Mediated Inducible β-Lactamase (DHA-1) with an ampR Gene from Morganella morganiiAntimicrobial Agents and Chemotherapy, 1998
- Chromosomally Encoded AmpC-Type β-Lactamase in a Clinical Isolate of Proteus mirabilisAntimicrobial Agents and Chemotherapy, 1998
- Novel transferable beta-lactam resistance with cephalosporinase characteristics in Salmonella enteritidisJournal of Antimicrobial Chemotherapy, 1997
- Characterization of an inhibitor-resistant enzyme IRT-2 derived from TEM-2 β-lactamase produced by Proteus mirabilis strainsJournal of Antimicrobial Chemotherapy, 1996
- Extended-spectrum β-lactamase in Proteus mirabilisJournal of Antimicrobial Chemotherapy, 1994